In a previous study on the same population (Norwegians), we found the APOBEC3A/B deletion not to be associated with reduced risk of any of the four major cancer types, breast, prostate, lung- or colon cancer, in overall assessments27. The gene discussed is APOBEC3A; the disease is cancer.